INVEGA

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug INVEGA contains one active pharmaceutical ingredient (API):

1	Paliperidone UNII 838F01T721 - PALIPERIDONE
	Paliperidone is a selective blocking agent of monoamine effects, whose pharmacological properties are different from that of traditional neuroleptics. Even though paliperidone is a strong D2-antagonist, which is believed to relieve the positive symptoms of schizophrenia, it causes less catalepsy and decreases motor functions to a lesser extent than traditional neuroleptics.
	Read more about Paliperidone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INVEGA Prolonged-release tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AX13	Paliperidone	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11066K, 11072R, 11085K, 11094X, 5100K, 5102M, 5103N, 5107T, 5109X, 9140C, 9141D, 9142E
BR	Câmara de Regulação do Mercado de Medicamentos	514506903119310, 514506905111317, 514506907114313, 514508401153411, 514508403156418, 514508404152416, 514508405159414, 514517090033503, 514517090033603, 514517090033703, 514517090033803, 514517090033903, 514519120035507, 514519120035607, 514519120035707, 514519120035807
CA	Health Products and Food Branch	02300273, 02300281, 02300303, 02354217, 02354225, 02354233, 02354241, 02455943, 02455986, 02455994, 02456001
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	04597242, 04597443, 04597905, 14261750
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	367560813, 5084-MEE-0420
EE	Ravimiamet	1299696, 1299708, 1299719, 1299720, 1299731, 1299742, 1299753, 1299764, 1299775, 1299786, 1299797, 1299809, 1299810, 1299821, 1299832, 1299843, 1299854, 1299865, 1299876, 1299887, 1299898, 1299900, 1299911, 1299922, 1473713, 1473724, 1473735, 1473746, 1473757, 1473768, 1473779, 1473780, 1473803, 1473814, 1473825
ES	Centro de información online de medicamentos de la AEMPS	107395041, 107395045, 107395049
GB	Medicines & Healthcare Products Regulatory Agency	117494, 117499, 117511
HK	Department of Health Drug Office	56191, 56192, 56193, 60141, 60142, 60144, 60145, 64970, 64971, 64972, 64973
IE	Health Products Regulatory Authority	29200, 29201, 29205, 29207, 29224, 29249, 29273
IL	מִשְׂרַד הַבְּרִיאוּת	6189, 6190, 6191
IT	Agenzia del Farmaco	038024016, 038024067, 038024117, 038024410, 038024459, 038024497
JP	医薬品医療機器総合機構	1179053G1023, 1179053G2020, 1179053G3026
LT	Valstybinė vaistų kontrolės tarnyba	1029242, 1029243, 1029244, 1029245, 1029246, 1029247, 1029248, 1029249, 1029250, 1029251, 1029252, 1029253, 1029254, 1029255, 1029256, 1029257, 1029258, 1029259, 1029260, 1029261, 1029262, 1029263, 1029264, 1029265, 1029266, 1029267, 1029268, 1029269, 1029270, 1029271, 1029272, 1029273, 1029274, 1029275, 1029276, 1029277, 1029278, 1029279, 1029280, 1029281, 1029282, 1029283, 1029284, 1029285, 1029286, 1029287, 1029288, 1029289, 1029290, 1029291, 1029292, 1029293, 1029294, 1029295, 1029296, 1029297, 1029298, 1029299, 1029300, 1029301, 1029302, 1029303, 1029304, 1029305, 1036862, 1036863, 1036864, 1036865, 1036866, 1036867, 1036868, 1036869, 1036870, 1036871, 1036872, 1036873, 1036874, 1036875, 1036876, 1036877, 1036878, 1036879, 1036880, 1036881, 1036882, 1036883, 1036884, 1036885, 1036886, 1036887, 1036888, 1036889, 1036890, 1036891, 1036892
NG	Registered Drug Product Database	B4-8221, B4-8222, B4-9906
NL	Z-Index G-Standaard, PRK	84638, 84646, 84654
NZ	Medicines and Medical Devices Safety Authority	13961, 13962, 13963, 13964, 13965, 17628, 17629, 17630, 17631
PL	Rejestru Produktów Leczniczych	100079760, 100179473, 100179705, 100179728
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W52104001, W52104002, W52104003, W52104004, W52104005, W52104006, W52104007, W52104008, W52104009, W52104010, W52104011, W52104012, W52104013, W52104014, W52104015, W52104016, W52105001, W52105002, W52105003, W52105004, W52105005, W52105006, W52105007, W52105008, W52105009, W52105010, W52105011, W52105012, W52105013, W52105014, W52105015, W52105016, W52106001, W52106002, W52106003, W52106004, W52106005, W52106006, W52106007, W52106008, W52106009, W52106010, W52106011, W52106012, W52106013, W52106014, W52106015, W52106016, W52107001, W52107002, W52107003, W52107004, W52107005, W52107006, W52107007, W52107008, W52107009, W52107010, W52107011, W52107012, W52107013, W52107014, W52107015, W52107016
SG	Health Sciences Authority	13380P, 13381P, 13382P, 13968P, 13969P, 13970P, 13971P, 13972P, 15186P, 15187P, 15188P, 15189P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699593035760, 8699593035784, 8699593035807, 8699593036019, 8699593036026, 8699593036033
US	FDA, National Drug Code	50458-550, 50458-551, 50458-552, 50458-554, 50458-560, 50458-561, 50458-562, 50458-563, 50458-564, 50458-606, 50458-607, 50458-608, 50458-609
ZA	Health Products Regulatory Authority	42/2.6.5/0284, 42/2.6.5/0285, 42/2.6.5/0286, 42/2.6.5/0287